The Federal Circuit recently affirmed dismissal of the patent owner’s lawsuit brought for patent infringement under the doctrine of equivalents in Amgen Inc. v. Coherus Biosciences Inc ., 2018-1993 (Fed. Cir. July 29, 2019). The case illustrates one of the potential ...